Zhejiang Xianju Pharmaceutical (002332.SZ): Injectable Veklury (Remdesivir) intended to be selected for centralized procurement.

Zhejiang Xianju Pharmaceutical (002332.SZ) announcement, the company participated in the bidding work for the eleventh batch of national centralized drug procurement organized by the National Drug Centralized Procurement Office from October 27 to October 28, 2025. The company's product Vecuronium Bromide for Injection is expected to be shortlisted in this centralized procurement. The indications for this drug are mainly used as an adjunct to general anesthesia, for tracheal intubation during general anesthesia and muscle relaxation during surgery.